Form 8-K - Current report:
SEC Accession No. 0001104659-24-124616
Filing Date
2024-12-02
Accepted
2024-12-02 16:34:45
Documents
51
Period of Report
2024-12-02
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2429902d1_8k.htm   iXBRL 8-K 33644
2 EXHIBIT 99.1 tm2429902d1_ex99-1.htm EX-99.1 54747
7 GRAPHIC tm2429902d1_ex99-1img001.jpg GRAPHIC 517719
8 GRAPHIC tm2429902d1_ex99-1img002.jpg GRAPHIC 1352269
9 GRAPHIC tm2429902d1_ex99-1img003.jpg GRAPHIC 949286
10 GRAPHIC tm2429902d1_ex99-1img004.jpg GRAPHIC 942699
11 GRAPHIC tm2429902d1_ex99-1img005.jpg GRAPHIC 846423
12 GRAPHIC tm2429902d1_ex99-1img006.jpg GRAPHIC 983726
13 GRAPHIC tm2429902d1_ex99-1img007.jpg GRAPHIC 583801
14 GRAPHIC tm2429902d1_ex99-1img008.jpg GRAPHIC 799825
15 GRAPHIC tm2429902d1_ex99-1img009.jpg GRAPHIC 661573
16 GRAPHIC tm2429902d1_ex99-1img010.jpg GRAPHIC 585109
17 GRAPHIC tm2429902d1_ex99-1img011.jpg GRAPHIC 945631
18 GRAPHIC tm2429902d1_ex99-1img012.jpg GRAPHIC 531586
19 GRAPHIC tm2429902d1_ex99-1img013.jpg GRAPHIC 614377
20 GRAPHIC tm2429902d1_ex99-1img014.jpg GRAPHIC 330727
21 GRAPHIC tm2429902d1_ex99-1img015.jpg GRAPHIC 662356
22 GRAPHIC tm2429902d1_ex99-1img016.jpg GRAPHIC 196946
23 GRAPHIC tm2429902d1_ex99-1img017.jpg GRAPHIC 440751
24 GRAPHIC tm2429902d1_ex99-1img018.jpg GRAPHIC 951136
25 GRAPHIC tm2429902d1_ex99-1img019.jpg GRAPHIC 717143
26 GRAPHIC tm2429902d1_ex99-1img020.jpg GRAPHIC 858801
27 GRAPHIC tm2429902d1_ex99-1img021.jpg GRAPHIC 720241
28 GRAPHIC tm2429902d1_ex99-1img022.jpg GRAPHIC 684284
29 GRAPHIC tm2429902d1_ex99-1img023.jpg GRAPHIC 477338
30 GRAPHIC tm2429902d1_ex99-1img024.jpg GRAPHIC 1025881
31 GRAPHIC tm2429902d1_ex99-1img025.jpg GRAPHIC 894449
32 GRAPHIC tm2429902d1_ex99-1img026.jpg GRAPHIC 534697
33 GRAPHIC tm2429902d1_ex99-1img027.jpg GRAPHIC 786104
34 GRAPHIC tm2429902d1_ex99-1img028.jpg GRAPHIC 523654
35 GRAPHIC tm2429902d1_ex99-1img029.jpg GRAPHIC 977762
36 GRAPHIC tm2429902d1_ex99-1img030.jpg GRAPHIC 954222
37 GRAPHIC tm2429902d1_ex99-1img031.jpg GRAPHIC 869983
38 GRAPHIC tm2429902d1_ex99-1img032.jpg GRAPHIC 801930
39 GRAPHIC tm2429902d1_ex99-1img033.jpg GRAPHIC 546789
40 GRAPHIC tm2429902d1_ex99-1img034.jpg GRAPHIC 922126
41 GRAPHIC tm2429902d1_ex99-1img035.jpg GRAPHIC 224726
42 GRAPHIC tm2429902d1_ex99-1img036.jpg GRAPHIC 769395
  Complete submission text file 0001104659-24-124616.txt   36312233

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA zbio-20241202.xsd EX-101.SCH 3260
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE zbio-20241202_def.xml EX-101.DEF 26190
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE zbio-20241202_lab.xml EX-101.LAB 35952
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zbio-20241202_pre.xml EX-101.PRE 24848
53 EXTRACTED XBRL INSTANCE DOCUMENT tm2429902d1_8k_htm.xml XML 5175
Mailing Address 852 WINTER STREET, SUITE 250 WALTHAM MA 02451
Business Address 852 WINTER STREET, SUITE 250 WALTHAM MA 02451 857-271-2954
Zenas BioPharma, Inc. (Filer) CIK: 0001953926 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42270 | Film No.: 241519538
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)